313 related articles for article (PubMed ID: 34105279)
1. Targeted RNA N
Chen X; Zhao Q; Zhao YL; Chai GS; Cheng W; Zhao Z; Wang J; Luo GZ; Cao N
Adv Sci (Weinh); 2021 Jun; 8(11):e2003902. PubMed ID: 34105279
[TBL] [Abstract][Full Text] [Related]
2. Stage-specific requirement for m
Dong S; Sun Y; Liu C; Li Y; Yu S; Zhang Q; Xu Y
Differentiation; 2023; 133():77-87. PubMed ID: 37506593
[TBL] [Abstract][Full Text] [Related]
3. ALKBH5-mediated m
Hao L; Yin J; Yang H; Li C; Zhu L; Liu L; Zhong J
Aging (Albany NY); 2021 Jan; 13(3):4045-4062. PubMed ID: 33428593
[TBL] [Abstract][Full Text] [Related]
4. ALKBH5 regulates cardiomyocyte proliferation and heart regeneration by demethylating the mRNA of YTHDF1.
Han Z; Wang X; Xu Z; Cao Y; Gong R; Yu Y; Yu Y; Guo X; Liu S; Yu M; Ma W; Zhao Y; Xu J; Li X; Li S; Xu Y; Song R; Xu B; Yang F; Bamba D; Sukhareva N; Lei H; Gao M; Zhang W; Zagidullin N; Zhang Y; Yang B; Pan Z; Cai B
Theranostics; 2021; 11(6):3000-3016. PubMed ID: 33456585
[TBL] [Abstract][Full Text] [Related]
5. Fate by RNA methylation: m6A steers stem cell pluripotency.
Zhao BS; He C
Genome Biol; 2015 Feb; 16(1):43. PubMed ID: 25723450
[TBL] [Abstract][Full Text] [Related]
6. Targeted mRNA demethylation using an engineered dCas13b-ALKBH5 fusion protein.
Li J; Chen Z; Chen F; Xie G; Ling Y; Peng Y; Lin Y; Luo N; Chiang CM; Wang H
Nucleic Acids Res; 2020 Jun; 48(10):5684-5694. PubMed ID: 32356894
[TBL] [Abstract][Full Text] [Related]
7. m
Nagaki Y; Motoyama S; Yamaguchi T; Hoshizaki M; Sato Y; Sato T; Koizumi Y; Wakita A; Kawakita Y; Imai K; Nanjo H; Watanabe H; Imai Y; Minamiya Y; Kuba K
Genes Cells; 2020 Aug; 25(8):547-561. PubMed ID: 32449584
[TBL] [Abstract][Full Text] [Related]
8. N
Ma X; Cao J; Zhou Z; Lu Y; Li Q; Jin Y; Chen G; Wang W; Ge W; Chen X; Hu Z; Shu X; Deng Q; Pu J; Liang C; Fu J; Liu J; Zhu S
Nat Commun; 2022 Jul; 13(1):4148. PubMed ID: 35851388
[TBL] [Abstract][Full Text] [Related]
9. The m6A demethylase ALKBH5 controls trophoblast invasion at the maternal-fetal interface by regulating the stability of
Li XC; Jin F; Wang BY; Yin XJ; Hong W; Tian FJ
Theranostics; 2019; 9(13):3853-3865. PubMed ID: 31281518
[TBL] [Abstract][Full Text] [Related]
10. Epitranscriptomic editing of the RNA N6-methyladenosine modification by dCasRx conjugated methyltransferase and demethylase.
Xia Z; Tang M; Ma J; Zhang H; Gimple RC; Prager BC; Tang H; Sun C; Liu F; Lin P; Mei Y; Du R; Rich JN; Xie Q
Nucleic Acids Res; 2021 Jul; 49(13):7361-7374. PubMed ID: 34181729
[TBL] [Abstract][Full Text] [Related]
11. Preparation of Human Nuclear RNA m⁶A Methyltransferases and Demethylases and Biochemical Characterization of Their Catalytic Activity.
Liu J; Yue Y; He C
Methods Enzymol; 2015; 560():117-30. PubMed ID: 26253968
[TBL] [Abstract][Full Text] [Related]
12. RBM33: A new regulator of N-6-methyladenosine (m
Zhang P; Abdel-Wahab O
Mol Cell; 2023 Jun; 83(12):1956-1958. PubMed ID: 37327770
[TBL] [Abstract][Full Text] [Related]
13. N6-methyladenosine demethylase ALKBH5 suppresses colorectal cancer progression potentially by decreasing PHF20 mRNA methylation.
Zhang Z; Wang L; Zhao L; Wang Q; Yang C; Zhang M; Wang B; Jiang K; Ye Y; Wang S; Shen Z
Clin Transl Med; 2022 Aug; 12(8):e940. PubMed ID: 35979628
[TBL] [Abstract][Full Text] [Related]
14. ALKBH5 regulates STAT3 activity to affect the proliferation and tumorigenicity of osteosarcoma via an m6A-YTHDF2-dependent manner.
Yang Z; Cai Z; Yang C; Luo Z; Bao X
EBioMedicine; 2022 Jun; 80():104019. PubMed ID: 35490460
[TBL] [Abstract][Full Text] [Related]
15. The epigenetic modifier ubiquitin-specific protease 22 (USP22) regulates embryonic stem cell differentiation via transcriptional repression of sex-determining region Y-box 2 (SOX2).
Sussman RT; Stanek TJ; Esteso P; Gearhart JD; Knudsen KE; McMahon SB
J Biol Chem; 2013 Aug; 288(33):24234-46. PubMed ID: 23760504
[TBL] [Abstract][Full Text] [Related]
16. ALKBH5 Promotes Multiple Myeloma Tumorigenicity through inducing m
Yu T; Yao L; Yin H; Teng Y; Hong M; Wu Q
Int J Biol Sci; 2022; 18(6):2235-2248. PubMed ID: 35414790
[TBL] [Abstract][Full Text] [Related]
17. N
Zhu Z; Qian Q; Zhao X; Ma L; Chen P
Gene; 2020 Mar; 731():144348. PubMed ID: 31927006
[TBL] [Abstract][Full Text] [Related]
18. Suppression of m6A mRNA modification by DNA hypermethylated ALKBH5 aggravates the oncological behavior of KRAS mutation/LKB1 loss lung cancer.
Zhang D; Ning J; Okon I; Zheng X; Satyanarayana G; Song P; Xu S; Zou MH
Cell Death Dis; 2021 May; 12(6):518. PubMed ID: 34016959
[TBL] [Abstract][Full Text] [Related]
19. ALKBH5-dependent m6A demethylation controls splicing and stability of long 3'-UTR mRNAs in male germ cells.
Tang C; Klukovich R; Peng H; Wang Z; Yu T; Zhang Y; Zheng H; Klungland A; Yan W
Proc Natl Acad Sci U S A; 2018 Jan; 115(2):E325-E333. PubMed ID: 29279410
[TBL] [Abstract][Full Text] [Related]
20. RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential.
Qu J; Yan H; Hou Y; Cao W; Liu Y; Zhang E; He J; Cai Z
J Hematol Oncol; 2022 Jan; 15(1):8. PubMed ID: 35063010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
